FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3016726980> ?p ?o ?g. }

• W3016726980 endingPage "258" @default.
• W3016726980 startingPage "248" @default.
• W3016726980 abstract "The superiority of stereotactic body radiotherapy (SBRT) combined with transcatheter arterial chemoembolization (TACE) compared to SBRT alone as the first-line therapy for unresectable hepatocellular carcinoma (HCC) remains unclear. We conducted this meta-analysis to compare the efficiency and safety of SBRT combined with TACE (ST group) and SBRT alone (SA group).We searched PubMed, Ovid Medline, Web of Science, Scopus, The Cochrane Library, ScienceDirect, EMBASE, Google Scholar, and CNKI (China National Knowledge Infrastructure) for related studies. We analyzed overall survival (OS), local control survival (LCS), progression-free survival (PFS), the response rate and adverse effects (AEs) between the 2 groups.Ten articles were included, with a total of 980 patients. The results showed that the ST (SBRT + TACE) group had a longer OS (95% CIs 0.60-0.85, p = 0.0002), a higher 5-year OS rate (95% CI 1.01-2.04, p = 0.04), a higher rate of complete response (95% CI 1.08-1.90, p = 0.01), and a higher disease control rate (95% CI 1.02-1.16, p = 0.02) than the SA (SBRT alone) group. No significant difference was found in LCS, PFS and total AEs of all grades and grades 3-5 AEs between the 2 groups. In the subgroup analysis, the patients with HCC + PVTT or treated with SBRT followed by TACE in the ST group had the same OS as those in the SA group, and the patients in the ST group had a higher incidence rate of leukopenia and fever than those in the SA group.SBRT + TACE appears to be more effective than SBRT alone in treating unresectable HCC. However, its higher incidence rate of leukopenia and fever need to be monitored." @default.
• W3016726980 created "2020-04-24" @default.
• W3016726980 creator A5003628502 @default.
• W3016726980 creator A5012278873 @default.
• W3016726980 creator A5023070419 @default.
• W3016726980 creator A5029642484 @default.
• W3016726980 creator A5035093874 @default.
• W3016726980 creator A5048213778 @default.
• W3016726980 creator A5050733356 @default.
• W3016726980 creator A5064907989 @default.
• W3016726980 creator A5070234700 @default.
• W3016726980 creator A5089116680 @default.
• W3016726980 date "2019-01-01" @default.
• W3016726980 modified "2023-10-15" @default.
• W3016726980 title "Stereotactic Body Radiotherapy Combined with Transcatheter Arterial Chemoembolization versus Stereotactic Body Radiotherapy Alone as the First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Meta-Analysis and Systematic Review" @default.
• W3016726980 cites W1247968195 @default.
• W3016726980 cites W1956985487 @default.
• W3016726980 cites W2038337463 @default.
• W3016726980 cites W2079586464 @default.
• W3016726980 cites W2088095316 @default.
• W3016726980 cites W2093874815 @default.
• W3016726980 cites W2156098321 @default.
• W3016726980 cites W2234453634 @default.
• W3016726980 cites W2334787726 @default.
• W3016726980 cites W2338748777 @default.
• W3016726980 cites W2548831512 @default.
• W3016726980 cites W2570618306 @default.
• W3016726980 cites W2591184874 @default.
• W3016726980 cites W2735215655 @default.
• W3016726980 cites W2735951177 @default.
• W3016726980 cites W2736204246 @default.
• W3016726980 cites W2796067155 @default.
• W3016726980 cites W2807653222 @default.
• W3016726980 cites W2810892286 @default.
• W3016726980 cites W2811191473 @default.
• W3016726980 cites W2889646458 @default.
• W3016726980 cites W2892501818 @default.
• W3016726980 cites W2967507210 @default.
• W3016726980 cites W2970937070 @default.
• W3016726980 cites W2991792334 @default.
• W3016726980 doi "https://doi.org/10.1159/000505739" @default.
• W3016726980 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32320982" @default.
• W3016726980 hasPublicationYear "2019" @default.
• W3016726980 type Work @default.
• W3016726980 sameAs 3016726980 @default.
• W3016726980 citedByCount "15" @default.
• W3016726980 countsByYear W30167269802021 @default.
• W3016726980 countsByYear W30167269802022 @default.
• W3016726980 countsByYear W30167269802023 @default.
• W3016726980 crossrefType "journal-article" @default.
• W3016726980 hasAuthorship W3016726980A5003628502 @default.
• W3016726980 hasAuthorship W3016726980A5012278873 @default.
• W3016726980 hasAuthorship W3016726980A5023070419 @default.
• W3016726980 hasAuthorship W3016726980A5029642484 @default.
• W3016726980 hasAuthorship W3016726980A5035093874 @default.
• W3016726980 hasAuthorship W3016726980A5048213778 @default.
• W3016726980 hasAuthorship W3016726980A5050733356 @default.
• W3016726980 hasAuthorship W3016726980A5064907989 @default.
• W3016726980 hasAuthorship W3016726980A5070234700 @default.
• W3016726980 hasAuthorship W3016726980A5089116680 @default.
• W3016726980 hasConcept C120665830 @default.
• W3016726980 hasConcept C121332964 @default.
• W3016726980 hasConcept C126322002 @default.
• W3016726980 hasConcept C143998085 @default.
• W3016726980 hasConcept C187960798 @default.
• W3016726980 hasConcept C197934379 @default.
• W3016726980 hasConcept C2776283816 @default.
• W3016726980 hasConcept C2776478404 @default.
• W3016726980 hasConcept C2778019345 @default.
• W3016726980 hasConcept C2778455285 @default.
• W3016726980 hasConcept C2780873365 @default.
• W3016726980 hasConcept C29730261 @default.
• W3016726980 hasConcept C509974204 @default.
• W3016726980 hasConcept C61511704 @default.
• W3016726980 hasConcept C71924100 @default.
• W3016726980 hasConcept C90924648 @default.
• W3016726980 hasConcept C95190672 @default.
• W3016726980 hasConceptScore W3016726980C120665830 @default.
• W3016726980 hasConceptScore W3016726980C121332964 @default.
• W3016726980 hasConceptScore W3016726980C126322002 @default.
• W3016726980 hasConceptScore W3016726980C143998085 @default.
• W3016726980 hasConceptScore W3016726980C187960798 @default.
• W3016726980 hasConceptScore W3016726980C197934379 @default.
• W3016726980 hasConceptScore W3016726980C2776283816 @default.
• W3016726980 hasConceptScore W3016726980C2776478404 @default.
• W3016726980 hasConceptScore W3016726980C2778019345 @default.
• W3016726980 hasConceptScore W3016726980C2778455285 @default.
• W3016726980 hasConceptScore W3016726980C2780873365 @default.
• W3016726980 hasConceptScore W3016726980C29730261 @default.
• W3016726980 hasConceptScore W3016726980C509974204 @default.
• W3016726980 hasConceptScore W3016726980C61511704 @default.
• W3016726980 hasConceptScore W3016726980C71924100 @default.
• W3016726980 hasConceptScore W3016726980C90924648 @default.
• W3016726980 hasConceptScore W3016726980C95190672 @default.
• W3016726980 hasIssue "5-6" @default.
• W3016726980 hasLocation W30167269801 @default.
• W3016726980 hasLocation W30167269802 @default.
• W3016726980 hasOpenAccess W3016726980 @default.

• next